Effects of increasing doses of apomorphine during stereotaxic neurosurgery in Parkinson's disease: clinical score and internal globus pallidus activity
- 1 August 1997
- journal article
- case report
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 104 (8-9) , 895-904
- https://doi.org/10.1007/bf01285557
Abstract
We analysed the firing activity of internal globus pallidus cells in two Parkinson's disease patients undergoing stereotaxic surgery. Both patients showed an advanced rigid-akinetic syndrome with disabling levodopa induced dyskinesias. Apomorphine, intraoperatively administered at doses (1–2 mg) inducing a short but clear clinical improvement without involuntary movements, reduced the pallidal discharge rate by >50% in both patients. An higher apomorphine dose (2.5 mg), tested in one hemisphere, blocked the firing activity with a time course independent from the occurrence of dyskinesias. These finding suggest that the reduction of internal pallidus excitability is one of the mechanisms underlying the efficacy of dopaminergic therapy, but also that changes in other basal ganglia stations are likely to be involved in dyskinesias.Keywords
This publication has 17 references indexed in Scilit:
- Basal ganglia and movement disorders: an updateTrends in Neurosciences, 1996
- Methods for microelectrode-guided posteroventral pallidotomyJournal of Neurosurgery, 1996
- Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological dataNeuroscience Letters, 1995
- Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidium in basal ganglia circuitryBrain Research Reviews, 1995
- Differential neuronal activity in segments of globus pallidus in Parkinsonʼs disease patientsNeuroReport, 1994
- Neurophysiological properties of pallidal neurons in Parkinson's diseaseAnnals of Neurology, 1994
- Chronic continuous and intermittentl-3,4-dihydroxyphenylalanine treatments differentially affect basal ganglia function in 6-hydroxydopamine lesioned rats—an autoradiographic study using [3H]flunitrazepamNeuroscience, 1993
- Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleusThe Lancet, 1991
- Primate models of movement disorders of basal ganglia originTrends in Neurosciences, 1990
- The functional anatomy of basal ganglia disordersTrends in Neurosciences, 1989